Novel therapeutic biosensor for indinavir-A protease inhibitor antiretroviral drug

Journal of Pharmaceutical and Biomedical Analysis

Volumn 49, Issue 2, 2009, Pages 498-501

  Ignaszak, A ^a   Hendricks, N ^a   Waryo, T ^a   Songa, E ^a   Jahed, N ^a   Ngece, R ^a   Al Ahmed, A ^a   Kgarebe, B ^a   Baker, P ^a   Iwuoha, E I ^a  

^a UNIVERSITY OF THE WESTERN CAPE   (South Africa)

Author keywords

Amperometric biosensor; Bioelectrode; CYP3A4; Drug metabolism biosensor; Indinavir

Indexed keywords

CYTOCHROME P450 3A4; DIDODECYLDIMETHYLAMMONIUM BROMIDE; INDINAVIR;

AMPEROMETRIC BIOSENSOR; ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG METABOLISM; ELECTROCHEMISTRY; ELECTRODE; PRIORITY JOURNAL; REACTION TIME;

AEROBIOSIS; ANAEROBIOSIS; BIOSENSING TECHNIQUES; CLINICAL TRIALS, PHASE I AS TOPIC; CYTOCHROME P-450 CYP3A; ELECTRICITY; ELECTROCHEMISTRY; ELECTRODES; ENZYMES, IMMOBILIZED; HIV INFECTIONS; HIV PROTEASE INHIBITORS; INDINAVIR; MOLECULAR STRUCTURE; OXIDATION-REDUCTION; PLATINUM; QUATERNARY AMMONIUM COMPOUNDS; SILVER; SILVER COMPOUNDS; WATER;

EID: 59049085371     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.10.025     Document Type: Article

References (26)

1. Shimada T., Yamazaki H., Miura M., Inui Y., and Guengerich F.P. J. Pharmacol. Ther. 270 (1994) 414-423
2. Maurel P. In: Ioannides C. (Ed). Cytochromes P450: Metabolic and Toxicological (1996), Aspects CRC Press, Inc., Boca Raton 241-270
3. Nakamura H., Nakasa H., Ishii I., Ariyoshi N., Igarashi T., Ohmowi S., and Kitara M. Drug Metab. Dispos. 30 (2002) 534-540
4. Ortiz de Montellano P.R., and Correia M.A. Annu. Rev. Pharmacol. Toxicol. 23 (1983) 481-503
5. Tinel M., Belgiti J., Descatoire V., Amouyal G., Letteron P., Geneve J., Larrey D., and Pessayre D. Biochem. Pharmacol. 36 (1987) 951-955
6. Iwuoha E.I., Joseph S., Zhang Z., Smith M.R., Fuhr U., and Ortiz de Montellano P.R. J. Pharm. Biomed. Anal. 17 (1998) 1101-1110
7. Joseph S., Rusling J.F., Lvov Y.M., Friedberg T., and Fuhr U. Biochem. Pharmacol. 65 (2003) 1817-1826
8. Chiba M., Hensleigh M., Nishime J.A., Balani S.K., and Lin J.H. Drug Metab. Dispos. 24 (1996) 307-314
9. Kumar G.N., Rodrigues D.A., Buko A.M., and Denissen J.F. J. Pharmacol. Exp. Ther. 277 (1996) 423-431
10. Chiba M., Hensleigh M., and Lin J.H. Biochem. Pharmacol. 53 (1997) 1187-1195
11. Fitzsimmons M.E., and Collins J.M. Drug Metab. Dispos. 25 (1997) 256-266
12. Collier A.C., Coombs R.W., and Schoenfeld D.A. New Engl. J. Med. 334 (1996) 1011-1017
13. Inaba T., Fischer N.E., Riddick D.S., Steward D.J., and Hidaka T. Toxicol. Lett. 93 (1997) 215-219
14. Barry M., Gibbons S., Back D., and Mulcahy F. Clin. Pharmacokinet. 32 (1997) 194-209
15. Bertz R.J., and Granneman G.R. Clin. Pharmacokinet. 32 (1997) 210-258
16. Chiba M. Drug Metab. Dispos. 25 (1997) 1219-1222
17. Bistolas N., Wollenberger U., Jung C., and Scheller F.W. Biosens. Bioelectron. 20 (2005) 2408-2423
18. Rusling J.F., and Nassar A.-E.F. J. Am. Chem. Soc. 115 (1993) 11891-11897
19. Lin R., Immous C.E., and Farmer P.J. J. Biol. Inorg. Chem. 5 (2000) 738-747
20. Shumyantseva V.V., Bulko T.V., Samenkova N.F., Kuznetsova G.P., Usanov S.A., Schulze H., Bachmann T.T., Schmid R.D., and Archakov A.I. J. Inorg. Biochem. 100 (2006) 1353-1357
21. Rusling J.F. In: Lvov Y., and Mohwald H. (Eds). Protein Architecture: Interfacing Molecular Assemblies and Immobilisation Biotechnology (2000), Marcel Dekker, New York 337-354
22. Black S.D., and Coon M.J. Adv. Enzymol. Relat. Areas Mol. Biol. 60 (1987) 35-87
23. Wazawa T., Matsuoka A., Tajima G., Sugawara Y., Nakamura K., and Shikama K. Biophys. J. 63 (1992) 544-550
24. Unadkat J.D., Wara D.W., Hughes M.D., Mathias A.A., Holland D.T., Paul M.E., Connor J., Huang S., Nguyen B.-Y., Watts D.H., Mofenson L.M., Smith E., Deutsch P., Kaiser K.A., and Tuomala R.T. Antimicrob. Agents Chemother. 51 (2007) 783-786
25. Anderson P. Clin. Pharmacol. Ther. 71 (2002) 280-285
26. Piscitelli S., Burstain A., Chaitt D., Alfaro R., and Fallon J. Lancet 355 (2000) 547-548